Skip to content

Endoscopic Full Thickness Resection for Gastric GIST

Prospective Clinical Study on Safety and Effectiveness of Endoscopic Full Thickness Resection for Treatment of Patients With Gastric Gastrointestinal Stromal Tumors (GIST)

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04198337
Acronym
EFTR
Enrollment
30
Registered
2019-12-13
Start date
2014-08-01
Completion date
2024-12-31
Last updated
2023-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric GIST

Brief summary

This is a clinical trial to evaluate the efficacy and safety of endoscopic full thickness resection for treatment of gastric GIST

Detailed description

To evaluate the clinical safety and efficacy of endoscopic full thickness resection (EFTR) for treatment of gastric GIST. A total of 30 patients will be recruited

Interventions

Endoscopic full thickness resection achieved by resecting the submucosal tumor using retraction techniques and submucosal dissection, followed by closure

Sponsors

Chinese University of Hong Kong
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Age \> 18 and ≤ 80 2. Gastric submucosal tumors located at cardia, lesser curvature and antrum 3. Size of the submucosal tumor between 10mm to 30mm as assessed by endoscopic

Exclusion criteria

1. Patients who are considered as unfit for general anesthesia 2. ASA class ≥ IV or moribund patients 3. Pregnancy 4. Gastric submucosal tumors located at greater curvature and fundus

Design outcomes

Primary

MeasureTime frameDescription
Complete resection of GIST30 daysComplete resection of the GIST defined by en-bloc resection in one piece by endoscopy with clear resection margins

Secondary

MeasureTime frameDescription
Adverse event rate30 daysAdverse event as defined by presence of either postoperative bleeding or leakage after closure
Perioperative mortality30 daysDeath within 30 days after procedure
Histolology assessment30 daysHistology outcome as defined by any involvement of the tumor margins after resection
Hospital stay30 daysLength of stay in hospital
technical success in complete resection1 dayTechnical success defined by complete endoscopic resection, closure of the defect and delivery of the specimen per orally without need of conversion to laparoscopic surgery

Countries

China

Contacts

Primary ContactPhilip Wai Yan Y Chiu, MD, FRCSEd
philipchiu@surgery.cuhk.edu.hk+85235053952
Backup ContactMan Yee Yung
myyung@surgery.cuhk.edu.hk+35052956

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026